Showing 721 - 740 results of 99,478 for search '(( 5 ng decrease ) OR ( 5 ((non decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.47s Refine Results
  1. 721
  2. 722
  3. 723
  4. 724
  5. 725

    DataSheet2_Treatment of wild-type mice with 2,3-butanediol, a urinary biomarker of Fmo5−/− mice, decreases plasma cholesterol and epididymal fat deposition.pdf by Sunil Veeravalli (5074115)

    Published 2022
    “…Our results indicate a microbial contribution to the phenotypic characteristic of Fmo5<sup>−/−</sup> mice of decreased plasma cholesterol and identify 2,3-butanediol as a potential agent for lowering plasma cholesterol.…”
  6. 726

    DataSheet1_Treatment of wild-type mice with 2,3-butanediol, a urinary biomarker of Fmo5−/− mice, decreases plasma cholesterol and epididymal fat deposition.PDF by Sunil Veeravalli (5074115)

    Published 2022
    “…Our results indicate a microbial contribution to the phenotypic characteristic of Fmo5<sup>−/−</sup> mice of decreased plasma cholesterol and identify 2,3-butanediol as a potential agent for lowering plasma cholesterol.…”
  7. 727
  8. 728
  9. 729
  10. 730

    Relationships between empty body lipid weight decrease and corrected amounts of pollutants excreted through faeces (faecal output–feed input) for TCDD (○, ●), and PCBs 153 (□, ■) and 126 (Δ, ▲) over a 57-day depuration period in ewes receiving a control well-fed and non-supplemented treatments (CTL: ○, □, Δ; <i>n</i> = 4), or an underfed and mineral oil supplemented treatment (UFMO: ●, ■, ▲; <i>n</i> = 5). by Sylvain Lerch (1494349)

    Published 2020
    “…<p>Relationships between empty body lipid weight decrease and corrected amounts of pollutants excreted through faeces (faecal output–feed input) for TCDD (○, ●), and PCBs 153 (□, ■) and 126 (Δ, ▲) over a 57-day depuration period in ewes receiving a control well-fed and non-supplemented treatments (CTL: ○, □, Δ; <i>n</i> = 4), or an underfed and mineral oil supplemented treatment (UFMO: ●, ■, ▲; <i>n</i> = 5).…”
  11. 731
  12. 732
  13. 733
  14. 734
  15. 735

    MCP-1-deficiency decreased CD11c-expressing cells via impairing the production of ROS and decreased activation of PLCγ2, Akt, and ERK upon M-CSF stimulation in BMM. by Woon-Ki Kim (447798)

    Published 2013
    “…<p>BMMs from WT (open bar) and MCP-1-KO mice (oblique-lined bar) were incubated in the presence of M-CSF (30 ng/ml) with U73122 (10 µM), Akt inhibitor IV (0.3 µM), PD098059 (5 µM), DPI (50 nM), NAC (3 mM), or H<sub>2</sub>O<sub>2</sub> (300 µM) for 4 d (A). *, <i>P</i><0.05; ***, <i>P</i><0.001 compared with vehicle-treated WT cells. …”
  16. 736
  17. 737
  18. 738

    Mutant channel with deletion of the S10 region has decreased surface expression in a stable HEK293 cell line. by Shumin Bian (191969)

    Published 2011
    “…Surface to total ratios were obtained by integration of the histograms. There is a 40% decrease in surface protein expression for the HSloΔS10 mutant determined by the surface to total HSlo ratio (+/− SEM, p = 0.032 in two sample t-test .n = 5).…”
  19. 739

    Significant decrease of SMAD4 protein in DBA iPSCs. by Jingping Ge (636557)

    Published 2015
    “…A) Slight decrease of mRNA level of <i>SMAD4</i> in the DBA iPSCs with <i>RPS19</i> or <i>RPL5</i> mutations. …”
  20. 740